跳至主要内容
临床试验/NCT02059200
NCT02059200已完成不适用

The Effectiveness of Mindfulness Based Compassionate Living in Recurrent Depression

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
1
主要终点
Beck Depression Inventory-II

研究概览

简要总结

Since a few years, Mindfulness Based Cognitive Therapy (MBCT) has been used as treatment for patients suffering from recurrent depression. Though a number of studies show that MBCT is effective in this population and MBCT reduces the chances of relapse/recurrence in recurrent depressive patients, the chance of a new depression developing after end of treatment is still considerable. Ergo, there is room for improvement.

Especially the development of a non-judging or compassionate attitude towards all experience seems to mediate the treatment effect. It is therefore our expectation that a follow-up intervention that focuses specifically on self-compassion could prove very useful in elaborating on the effects of MBCT.

The research question of this research is therefore: what is the effect of compassion training in people suffering from recurrent depression who have already received MBCT training?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recurrent depression according to the DSM-IV criteria.
  • Having participated in an MBCT training (>= 4 sessions)

排除标准

  • One or more previous (hypo)manic episodes according to DSM-IV criteria.
  • Primary psychotic disorder, e.g. schizophrenia or delusions.
  • Clinically relevant neurological conditions (e.g. brain trauma or dementia) or somatic conditions (e.g. cancer, AIDS) that could be related to the depression.
  • Current alcohol and/or drug abuse.
  • Use of high dosages of benzodiazepines.
  • Recent electro convulsive therapy (ECT) (less than 3 months ago).
  • Problems impeding participating in a group, such as severe borderline personality disorder.
  • No prior experience with MBCT.
  • Problems impeding completing the questionnaires, such as cognitive dysfunctions (only assessed if suspected).
  • Subnormal intelligence (IQ < 80) (only assessed if suspected).

结局指标

主要结局

Beck Depression Inventory-II

时间窗: 1 year

The BDI-II measures depression symptoms. Measurements will be taken at baseline, end of treatment/control and follow up.

次要结局

  • Five Facet Mindfulness Questionnaire(1 year)
  • The Acceptance and Action Questionnaire-II(1 year)
  • Self-Compassion Scale(1 year)
  • Fears of Compassion Scale (3)(1 year)
  • The Ruminative Response Scale(1 year)
  • The Childhood Trauma Questionnaire(Baseline)
  • Types of Positive Affect Scale(1 year)
  • The World Health Organization Quality of Life Scale(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne Speckens

Professor

Radboud University Medical Center

研究点 (1)

Loading locations...

相似试验